Nyxoah SA (NYXH)
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Last price
- $0.90
- As of
Kresmion compiles this page from NYXH's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Nyxoah SA (NYXH): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-10-20.
See the full NYXH dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for NYXH on one page. Preview it with sample data, then open it live with a free account.
Preview the NYXH dossierActive events for NYXH
- mediumEarnings below estimates
Q2-2026: Missed consensus by 47.0%, EPS $-0.5799 vs $-0.3946 estimate
- mediumEarnings above estimates
Q2-2025: Beat consensus by 5.2% - EPS $-0.551 vs $-0.581 estimate
- mediumEarnings above estimates
Beat consensus by 5.2% - EPS $-0.551 vs $-0.581 estimate
- mediumEarnings below estimates
Q3-2025: Missed consensus by 5.0% - EPS $-0.63 vs $-0.5999 estimate
- mediumEarnings below estimates
Q4-2025: Missed consensus by 5.5% - EPS $-0.586 vs $-0.5554 estimate
FREE, NO ACCOUNT
Every event on NYXH, as it fires
You are seeing 5 of 6 events recorded on NYXH since 2026-06-11.
The five above landed across 3 days. The other 1 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, NYXH
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
NYXH against its peers
NYXH's operating margin of -833.2% ranks in the 13th percentile of 18 Medical Instruments & Supplies sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-06-30.
| Metric | NYXH | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 10.0M EUR | n/a | n/a | 0 |
| Revenue YoY | 121.6% | n/a | n/a | 3 |
| Gross margin | 63.1% | 57.4% | 76 | 18 |
| Operating margin | -833.2% | -33.2% | 13 | 18 |
| Net margin | -899.1% | -36.4% | 13 | 19 |
| Return on equity | -183.4% | -20.2% | 28 | 19 |
Peers (22): STXS, MBOT, KRMD, ZJYL, POCI, NNNN, NEPH, HBIO, PDEX, UTMD, MLSS, OSUR, SMTI, EMBC, RVP, BNGO, FEMY, CUPR, AVR, UEEC, RGNT, LUCY. Left out: DXR (no annual filing), ZTEKF (no annual filing), DAVI (no annual filing). Fiscal periods ending between 2025-09-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (NYXH: 20-F), reported in EUR. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow NYXH on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to NYXH for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.